1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

venBio Select Advisor LLC Buys Loxo Oncology Inc, Sarepta Therapeutics Inc, Amarin Corp PLC, Sells Endocyte Inc, Puma Biotechnology Inc, Madrigal Pharmaceuticals Inc

San Francisco, CA, based Investment company venBio Select Advisor LLC buys Loxo Oncology Inc, Sarepta Therapeutics Inc, Amarin Corp PLC, Zogenix Inc, Proteostasis Therapeutics Inc, Global Blood Therapeutics Inc, sells Endocyte Inc, Puma Biotechnology Inc, Madrigal Pharmaceuticals Inc, Clovis Oncology Inc, Catalyst Pharmaceuticals Inc, Arrowhead Pharmaceuticals Inc, Sesen Bio Inc, PTC Therapeutics Inc, Vanda Pharmaceuticals Inc, CRISPR Therapeutics AG, Tesaro Inc, Acer Therapeutics Inc, ACADIA Pharmaceuticals Inc, DBV Technologies SA, OncoSec Medical Inc, Principia Biopharma Inc during the 3-months ended 2018Q4, according to the most recent filings of the investment company, venBio Select Advisor LLC. As of 2018Q4, venBio Select Advisor LLC owns 31 stocks with a total value of $1.6 billion. These are the details of the buys and sells.

For the details of venBio Select Advisor LLC's stock buys and sells, go to https://www.gurufocus.com/guru/venbio+select+advisor+llc/current-portfolio/portfolio

These are the top 5 holdings of venBio Select Advisor LLC
  1. Immunomedics Inc (IMMU) - 17,714,461 shares, 15.45% of the total portfolio.
  2. Mirati Therapeutics Inc (MRTX) - 4,798,101 shares, 12.44% of the total portfolio.
  3. Sarepta Therapeutics Inc (SRPT) - 1,275,000 shares, 8.51% of the total portfolio. Shares added by 35.14%
  4. Ascendis Pharma A/S (ASND) - 1,980,000 shares, 7.58% of the total portfolio. Shares added by 0.85%
  5. Biomarin Pharmaceutical Inc (BMRN) - 1,360,000 shares, 7.08% of the total portfolio. Shares reduced by 0.59%
New Purchase: Loxo Oncology Inc (LOXO)

venBio Select Advisor LLC initiated holding in Loxo Oncology Inc. The purchase prices were between $127.8 and $176.35, with an estimated average price of $150.91. The stock is now traded at around $234.66. The impact to a portfolio due to this purchase was 2.78%. The holding were 325,000 shares as of .

New Purchase: Proteostasis Therapeutics Inc (PTI)

venBio Select Advisor LLC initiated holding in Proteostasis Therapeutics Inc. The purchase prices were between $1.75 and $10.35, with an estimated average price of $4.87. The stock is now traded at around $4.33. The impact to a portfolio due to this purchase was 0.26%. The holding were 1,300,000 shares as of .

Added: Sarepta Therapeutics Inc (SRPT)

venBio Select Advisor LLC added to a holding in Sarepta Therapeutics Inc by 35.14%. The purchase prices were between $97.32 and $147.38, with an estimated average price of $124.11. The stock is now traded at around $123.85. The impact to a portfolio due to this purchase was 2.21%. The holding were 1,275,000 shares as of .

Added: Amarin Corp PLC (AMRN)

venBio Select Advisor LLC added to a holding in Amarin Corp PLC by 37.82%. The purchase prices were between $12.41 and $22.98, with an estimated average price of $18.17. The stock is now traded at around $19.01. The impact to a portfolio due to this purchase was 1.27%. The holding were 5,575,000 shares as of .

Added: Zogenix Inc (ZGNX)

venBio Select Advisor LLC added to a holding in Zogenix Inc by 35.47%. The purchase prices were between $34.16 and $44.66, with an estimated average price of $40.82. The stock is now traded at around $52.42. The impact to a portfolio due to this purchase was 1.15%. The holding were 1,975,000 shares as of .

Added: Global Blood Therapeutics Inc (GBT)

venBio Select Advisor LLC added to a holding in Global Blood Therapeutics Inc by 21.74%. The purchase prices were between $31.54 and $46.67, with an estimated average price of $37.55. The stock is now traded at around $51.15. The impact to a portfolio due to this purchase was 0.16%. The holding were 350,000 shares as of .

Sold Out: Endocyte Inc (ECYT)

venBio Select Advisor LLC sold out a holding in Endocyte Inc. The sale prices were between $14.93 and $24, with an estimated average price of $22.16.

Sold Out: Puma Biotechnology Inc (PBYI)

venBio Select Advisor LLC sold out a holding in Puma Biotechnology Inc. The sale prices were between $20.07 and $46.7, with an estimated average price of $29.42.

Sold Out: Clovis Oncology Inc (CLVS)

venBio Select Advisor LLC sold out a holding in Clovis Oncology Inc. The sale prices were between $11.63 and $32.67, with an estimated average price of $20.2.

Sold Out: Catalyst Pharmaceuticals Inc (CPRX)

venBio Select Advisor LLC sold out a holding in Catalyst Pharmaceuticals Inc. The sale prices were between $1.92 and $3.58, with an estimated average price of $2.83.

Sold Out: Arrowhead Pharmaceuticals Inc (ARWR)

venBio Select Advisor LLC sold out a holding in Arrowhead Pharmaceuticals Inc. The sale prices were between $10.74 and $19.7, with an estimated average price of $13.53.

Sold Out: Sesen Bio Inc (SESN)

venBio Select Advisor LLC sold out a holding in Sesen Bio Inc. The sale prices were between $0.96 and $2.04, with an estimated average price of $1.58.

Reduced: Madrigal Pharmaceuticals Inc (MDGL)

venBio Select Advisor LLC reduced to a holding in Madrigal Pharmaceuticals Inc by 51.4%. The sale prices were between $94.77 and $215.54, with an estimated average price of $151.78. The stock is now traded at around $140.09. The impact to a portfolio due to this sale was -2.42%. venBio Select Advisor LLC still held 225,000 shares as of .

Reduced: PTC Therapeutics Inc (PTCT)

venBio Select Advisor LLC reduced to a holding in PTC Therapeutics Inc by 44.44%. The sale prices were between $29.83 and $45.28, with an estimated average price of $35.64. The stock is now traded at around $37.77. The impact to a portfolio due to this sale was -0.68%. venBio Select Advisor LLC still held 380,000 shares as of .

Reduced: Acer Therapeutics Inc (ACER)

venBio Select Advisor LLC reduced to a holding in Acer Therapeutics Inc by 46.43%. The sale prices were between $16.55 and $29.1, with an estimated average price of $22.82. The stock is now traded at around $23.75. The impact to a portfolio due to this sale was -0.19%. venBio Select Advisor LLC still held 150,000 shares as of .



Here is the complete portfolio of venBio Select Advisor LLC. Also check out:

1. venBio Select Advisor LLC's Undervalued Stocks
2. venBio Select Advisor LLC's Top Growth Companies, and
3. venBio Select Advisor LLC's High Yield stocks
4. Stocks that venBio Select Advisor LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)